Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jones Pharmaceuticals
St. Louis, Missouri, USA
- Ownership
- Private
- Development stage
- Other
01
Overview
Jones Pharmaceuticals, formerly known as Jones Medical Industries, was a specialty pharmaceutical company focused on the development and commercialization of branded prescription products. The company established a strong market presence in the endocrinology sector, particularly in thyroid health, with its flagship product Levoxyl. Jones Pharmaceuticals also marketed treatments for other conditions, including infectious diseases and critical care. In 2000, the company was acquired by King Pharmaceuticals for approximately $3.4 billion, which was subsequently acquired by Pfizer in 2011.
- Therapeutic areas
- EndocrinologyOtherInfectious Diseases
- Modalities
- Small moleculeHormoneRadiopharmaceutical
- Industry
- Biotech
Beyond the preview
Go deeper on Jones Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jones Pharmaceuticals.